Los Angeles Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,110
| Closed | -$515K | – | 1563 |
|
|
2020
Q3 | $515K | Sell |
2,110
-591
| -22% | -$144K | ﹤0.01% | 1070 |
|
|
2020
Q2 | $778K | Buy |
2,701
+743
| +38% | +$214K | ﹤0.01% | 944 |
|
|
2020
Q1 | $399K | Buy |
1,958
+957
| +96% | +$195K | ﹤0.01% | 977 |
|
|
2019
Q4 | $447K | Buy |
1,001
+213
| +27% | +$95.1K | ﹤0.01% | 1044 |
|
|
2019
Q3 | $242K | Buy |
788
+432
| +121% | +$133K | ﹤0.01% | 1174 |
|
|
2019
Q2 | $113K | Buy |
+356
| New | +$113K | ﹤0.01% | 1318 |
|